Development and Evaluation of a New Frailty Index for Older Surgical Patients With Cancer.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
03 05 2019
Historique:
entrez: 11 5 2019
pubmed: 11 5 2019
medline: 15 2 2020
Statut: epublish

Résumé

Frailty based on the modified Frailty Index is associated with poor postoperative outcomes. However, the index requires high levels of personnel time and effort and often has missing data. To evaluate the association of the Memorial Sloan Kettering-Frailty Index (MSK-FI) with established geriatric assessment (GA) and surgical outcomes. This cohort study included prospectively evaluated patients with cancer 75 years and older who were referred to MSK Geriatrics Service clinics for preoperative evaluation before undergoing surgery requiring hospitalization between February 2015 and September 2017. Patients were comanaged by the Geriatrics Service and Surgery Service in the postoperative period. Impairments identified by GA and comorbid conditions retrieved from submitted International Classification of Diseases, Ninth Revision (ICD-9) and ICD-10 codes within the first 48 hours of hospitalization. The association of MSK-FI score (which included ICD-9 and ICD-10 codes) with GA impairments (based on clinical interview and examination as well as patient reports) was examined. The associations of MSK-FI score with short-term surgical outcomes (ie, frequency of complications, length of stay, 30-day surgical complications, 30-day intensive care unit admissions, and 30-day readmissions) and 1-year survival, estimated by Kaplan-Meier methods, were determined. In total, 1137 patients (median [interquartile range] age, 80 [77-84] years; 583 [51.2%] women) were included in the study. A higher MSK-FI score was associated with the number of GA impairments (ρ = 0.52; bootstrapped 95% CI, 0.47-0.56). Each 1-point increase in MSK-FI score was associated with longer length of stay (0.58 d; 95% CI, 0.22-0.95; P = .002) and higher odds of intensive care unit admission (odds ratio, 1.28; 95% CI, 1.04-1.58; P = .02). Median (interquartile range) follow-up among survivors was 12.1 (5.6-19.1) months. The MSK-FI score was associated with overall mortality; 12-month risk of death was 5% for a score of 0 and approximately 20% for scores of 4 and higher (nonlinear association, P = .005). In this study, the MSK-FI was associated with the previously validated GA and postoperative outcomes in older patients with cancer and may be a feasible tool for perioperative assessment of older surgical patients with cancer. Future studies should assess the association of MSK-FI score with postoperative care and outcomes of older, frail patients with cancer.

Identifiants

pubmed: 31074814
pii: 2733174
doi: 10.1001/jamanetworkopen.2019.3545
pmc: PMC6512296
doi:

Types de publication

Journal Article Observational Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e193545

Subventions

Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States

Commentaires et corrections

Type : CommentIn

Références

Clin Geriatr Med. 2011 Feb;27(1):17-26
pubmed: 21093719
J Clin Oncol. 2014 Aug 20;32(24):2647-53
pubmed: 25071124
J Occup Med. 1976 Mar;18(3):165-8
pubmed: 1255276
Arch Surg. 1999 Jan;134(1):36-42
pubmed: 9927128
J Oncol Pract. 2017 Feb;13(2):95-102
pubmed: 28972834
J Nutr Health Aging. 2012 Aug;16(8):732-5
pubmed: 23076517
Rev Port Cir Cardiotorac Vasc. 2017 Jul-Dec;24(3-4):132
pubmed: 29701364
J Am Coll Surg. 2010 Jun;210(6):901-8
pubmed: 20510798
J Natl Compr Canc Netw. 2017 Feb;15(2):172-179
pubmed: 28188187
Int J Surg. 2015 Jun;18:184-90
pubmed: 25937154
Ann Thorac Surg. 2013 Oct;96(4):1240-1245
pubmed: 23915593
J Orthop Trauma. 2014 Mar;28(3):e49-55
pubmed: 23912859
J Surg Res. 2013 Jul;183(1):40-6
pubmed: 23273884
Ann Oncol. 2015 Jun;26(6):1091-101
pubmed: 25403592
Gynecol Oncol. 2015 Apr;137(1):98-101
pubmed: 25602715
JAMA Surg. 2017 Feb 1;152(2):205-207
pubmed: 27784060
Am J Emerg Med. 2015 May;33(5):713-8
pubmed: 25863652
J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M146-56
pubmed: 11253156
CMAJ. 2015 Aug 11;187(11):799-804
pubmed: 26009583
Ann Surg. 2009 Aug;250(2):187-96
pubmed: 19638912
Eur J Surg Oncol. 2016 Feb;42(2):297-302
pubmed: 26718329
Crit Rev Oncol Hematol. 2010 Dec;76(3):208-17
pubmed: 20005123
Ann Surg. 2010 Aug;252(2):325-9
pubmed: 20647925
Ann Surg Oncol. 2015 Apr;22(4):1061-7
pubmed: 25319579
Aging Clin Exp Res. 2007 Apr;19(2):145-53
pubmed: 17446726
J Am Geriatr Soc. 2005 Sep;53(9):1476-82
pubmed: 16137275
Ann Thorac Surg. 2008 Jun;85(6):1857-65; discussion 1865
pubmed: 18498784
Lancet. 2018 May 5;391(10132):1775-1782
pubmed: 29706364

Auteurs

Armin Shahrokni (A)

Geriatrics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.

Amy Tin (A)

Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.

Koshy Alexander (K)

Geriatrics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.

Saman Sarraf (S)

Geriatrics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.

Anoushka Afonso (A)

Department of Anesthesiology and Critical Care Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.

Olga Filippova (O)

Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.

Jennifer Harris (J)

Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.

Robert J Downey (RJ)

Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.

Andrew J Vickers (AJ)

Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.

Beatriz Korc-Grodzicki (B)

Geriatrics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH